WOODCLIFF LAKE, N.J. (AP) _ Eagle Pharmaceuticals Inc. (EGRX) on Monday reported first-quarter net income of $44.1 million, after reporting a loss in the same period a year earlier.On a per-share basis, the Woodcliff Lake, New Jersey-based company said it had net income of $3.41. Earnings, adjusted for stock option expense and non-recurring costs, came to $4.04 per share.The specialty pharmaceutical company posted revenue of $115.9 million in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EGRX at https://www.zacks.com/ap/EGRX